Adagio Medical Holdings, Inc. Ratios | P/E, ROE & Valuation

On the Key Ratios page for Adagio Medical Holdings, Inc. (ADGM), the latest P/E of -0.4 frames valuation, while ROE -661.85% and ROIC -74.66% indicates profitability and capital efficiency. Together with the current ratio of 1.41 and debt-to-equity -62.65, these signals help you judge whether valuation is supported by fundamentals across the historical rows.

Financial Performance Ratios

ADGM Historical Per Share Metrics

6 years
Metric (FY)TTM20242023202220212020
Revenue per Share$0.00$0.02$0.04$0.01$0.01$0.00
Net Income per Share$-1.22$-3.54$-4.86$0.06$-0.34$-0.00
Operating Cash Flow per Share$-0.74$-1.05$-3.27$-0.03$-1.01$0.00
Free Cash Flow per Share$-0.73$-1.08$-3.31$-0.05$-0.12$0.00
Cash per Share$0.35$1.35$0.18$0.29$0.03$0.00
Book Value per Share$-0.02$1.31$-5.36$-5.00$7.26$-0.00
Tangible Book Value per Share$-0.96$-0.07$-5.36$-5.00$7.26$-0.00
Interest Debt per Share$1.31$1.00$5.30$0.52$0.00$0.00
CAPEX per Share$0.02$0.02$0.04$0.03$0.07$0.00

ADGM Historical Valuation Ratios

6 years
Metric (FY)TTM20242023202220212020
Price to Earnings (P/E)-0.37-0.3-1.86162.66-26.46-12825.01
Price to Book (P/B)-28.360.8-1.69-1.811.25-12825.01
Price to Sales (P/S)059.32236.98918.72643.10
Enterprise Value to EBITDA-1.29-0.19-4-7.6-8.83-12825.84
EV to Sales043.26365.55941.21641.250
EV to Operating Cash Flow-1.82-0.73-4.28-366.63-8.970
EV to Free Cash Flow-1.85-0.71-4.22-180.2-73.920
Enterprise Value$30.03M$11.64M$109.67M$177.89M$173.14M$173.65M

ADGM Historical Profitability Ratios

6 years
Metric (FY)TTM20242023202220212020
Return on Equity (ROE)-661.85%-270.00%90.59%-1.11%-4.71%100.00%
Return on Invested Capital (ROIC)-74.66%-153.03%1301.44%-18.71%-4.58%582.82%
Return on Tangible Assets-209.58%-195.42%-558.92%12.27%-4.36%-31.89%
Earnings Yield-230.57%-336.90%-53.66%0.61%-3.78%-0.01%
Free Cash Flow Yield-137.61%-102.51%-36.56%-0.57%-1.35%0.00%
Dividend Yield0.00%0.00%0.00%0.00%0.00%0.00%

ADGM Historical Liquidity & Financial Strength

6 years
Metric (FY)TTM20242023202220212020
Current Ratio1.413.270.110.520.150.03
Interest Coverage-6.3856.7-16.84-7.3700
Income Quality8.060.750.67-0.450.970
Debt to Equity-62.650.82-0.95-0.10-0.83
Debt to Assets76.74%33.57%585.42%112.65%0.00%26.42%
Net Debt to EBITDA-0.790.07-1.41-0.180.03-0.83

ADGM Historical Efficiency Ratios

6 years
Metric (FY)TTM20242023202220212020
Receivables Turnover07.694.2308.180
Payables Turnover0.130.680.340.8720
Inventory Turnover0.040.750.392.383.470
Days Sales Outstanding047.4986.38044.610
Days Payables Outstanding2866.69535.161070.41421.73182.180
Days of Inventory on Hand8144.83483.53928.43153.09105.280

ADGM Historical Market Metrics

6 years
Metric (FY)TTM20242023202220212020
Enterprise Value to EBITDA-1.29-0.19-4-7.6-8.83-12825.84
Market Cap$11.77M$15.96M$71.09M$173.64M$173.64M$173.64M
Enterprise Value$30.03M$11.64M$109.67M$177.89M$173.14M$173.65M
Dividend Yield0.00%0.00%0.00%0.00%0.00%0.00%
Payout Ratio0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions

How does Adagio Medical Holdings, Inc.’s P/E ratio compare with its history?

On this page, ADGM's current P/E is -0.4, compared with a multi-year average around 162.7. A lower P/E versus its own history is a calculated gap versus that average—not a conclusion that the stock is cheap. Pair it with profitability and earnings quality in the table (for example ROE/ROIC) to see whether the multiple moved with earnings.

What is Adagio Medical Holdings, Inc. market cap?

Market cap is the market value of a company's equity and is commonly calculated as share price multiplied by shares outstanding. The latest market cap shown in the table is $11.77M. Pair market cap with valuation multiples (P/E, P/B, P/S) so you can evaluate whether size also corresponds with "quality" and profitability. For a wider view across stocks, you can also use the stock screener.

How does Adagio Medical Holdings, Inc.’s P/E compare with its industry?

There is no P/E Tickerplace rates as good. Compare the P/E on this page with Adagio Medical Holdings, Inc.'s own historical range (in the table) and with peers via the Screener and Compare tools. A higher or lower multiple versus peers is a calculated gap, not a recommendation.

How does Adagio Medical Holdings, Inc. compare to its competitors in key financial ratios?

The fastest way to compare Adagio Medical Holdings, Inc. with competitors is to use the built-in "Peers Comparison" section on this page and the Compare tool. Focus on a small set of ratios that work together: P/E for valuation, ROE/ROIC for profitability and capital efficiency, current ratio and interest coverage for liquidity and solvency, and debt-to-equity for leverage risk. When you see Adagio Medical Holdings, Inc. outperform peers on profitability while keeping valuation and leverage reasonable, it often signals stronger fundamentals.

What do Adagio Medical Holdings, Inc.'s liquidity and leverage ratios show?

Liquidity and leverage figures on this page are published ratios, not a verdict that Adagio Medical Holdings, Inc. is financially strong. Current ratio is about 1.41, which is above 1.0 and can indicate more comfortable short-term liquidity. Interest coverage is about -6.38, implying less buffer for servicing interest costs. Debt-to-equity is about -62.65, suggesting leverage is more moderate relative to a high-debt profile. Pair them with ROE/ROIC and cash-flow rows in the table. Tickerplace does not rate the company as a good or poor investment.

What do Adagio Medical Holdings, Inc.'s financial ratios say about its future growth?

Ratios are a way to see what the business is likely to sustain. Look for upward trends in profitability metrics (ROE and ROIC), improving earnings/cash-flow backed measures, and stable or strengthening liquidity. If Adagio Medical Holdings, Inc. is sustaining strong returns (for example ROE at -661.85% and ROIC at -74.66%) while debt levels and interest coverage remain manageable, growth expectations may be more credible. If valuation multiples expand while returns weaken, the market may be pricing optimistic growth ahead of results.